CD8A and neoplasm: Interestingly, except that TIGIT was reported to be expressed on NK and T cells, the expression of PVR was also observed on CD4+ T cells, CD8+ T cells and NK cells (Figure S7), indicating the function of these cells might be suppressed by TIGIT on tumor cells via interaction with PVR.